Funder: National Institutes of Health (NIH)
Due Dates: October 5, 2025 (forecasted)
Funding Amounts: R01 mechanism; award ceiling/floor not yet specified; multi-year support possible
Summary: Supports multi-site Phase Ib to III clinical trials of interventions for prevention, delay, or treatment of Alzheimer’s disease and related dementias via the ACTC network.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.